{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:57:33Z","timestamp":1793746653061,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejrad.2025.112156","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:26:51Z","timestamp":1746530811000},"page":"112156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["DWI\/ADC in response assessment after local-regional treatment of HCC \u2013 Pearls and Pitfalls"],"prefix":"10.1016","volume":"188","author":[{"given":"Liang Meng","family":"Loy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo Yuan","family":"How","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien Min","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uei","family":"Pua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Han","family":"Hwee Quek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cher Heng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2025.112156_b0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2214\/AJR.13.10706","article-title":"Imaging Assessment of Hepatocellular Carcinoma Response to Locoregional and Systemic Therapy","volume":"201","author":"Yaghmai","year":"2013","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ejrad.2025.112156_b0010","article-title":"Mri assessment of hepatocellular carcinoma after localregional therapy: A comprehensive review. Radiol Imaging","volume":"2","author":"Mendiratta-Lala","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2025.112156_b0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejrad.2025.112156_b0020","first-page":"2342","article-title":"Yttrium-90 Radioembolization for the Treatment of Solitary","volume":"74","author":"Salem","year":"2021","journal-title":"Unresectable HCC: the LEGACY Study. Hepatology"},{"key":"10.1016\/j.ejrad.2025.112156_b0025","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jmri.25369","article-title":"Imaging review of hepatocellular carcinoma after thermal ablation: The good, the bad, and the ugly","volume":"44","author":"Bouda","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0030","first-page":"488","article-title":"Barcelona Clinic Liver Cancer 2022 update: Linking prognosis prediction and evidence-based treatment recommendation with multidisciplinary clinical decision-making","volume":"42","author":"Mauro","year":"2022","journal-title":"Liver Int off J Int Assoc Study Liver"},{"key":"10.1016\/j.ejrad.2025.112156_b0035","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00270-022-03072-8","article-title":"TARE in Hepatocellular Carcinoma: From the Right to the Left of BCLC","volume":"45","author":"Guiu","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"10.1016\/j.ejrad.2025.112156_b0040","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.32035","article-title":"LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features","volume":"224","author":"Zhou","year":"2025","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejrad.2025.112156_b0045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1148\/radiol.2019191581","article-title":"The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma","volume":"294","author":"Chaudhry","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112156_b0050","doi-asserted-by":"crossref","unstructured":"Elsayes KM, Hooker JC, Agrons MM, Kielar AZ, Tang A, Fowler KJ, et al. 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiogr a Rev Publ Radiol Soc North Am Inc 2017;37:1994\u20132017. https:\/\/doi.org\/10.1148\/rg.2017170098.","DOI":"10.1148\/rg.2017170098"},{"key":"10.1016\/j.ejrad.2025.112156_b0055","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00261-018-1744-4","article-title":"White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI","volume":"43","author":"Elsayes","year":"2018","journal-title":"Abdom Radiol (new York)"},{"key":"10.1016\/j.ejrad.2025.112156_b0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiol.2020192484","article-title":"LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating","volume":"294","author":"Do","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112156_b0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver Imaging Reporting and Data System (LI-RADS) version 2018: Imaging of hepatocellular carcinoma in at-risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112156_b0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2020192797","article-title":"Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI","volume":"296","author":"Park","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112156_b0075","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00330-019-06623-9","article-title":"LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features","volume":"30","author":"Kim","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0080","year":"2024","journal-title":"Am Coll Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0085","year":"2024","journal-title":"Am Coll Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0090","first-page":"3","article-title":"Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis","volume":"20","author":"Liu","year":"2020","journal-title":"Cancer Imaging off Publ Int Cancer Imaging Soc"},{"key":"10.1016\/j.ejrad.2025.112156_b0095","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2214\/AJR.21.26982","article-title":"Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review","volume":"219","author":"Loy","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejrad.2025.112156_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crad.2013.07.022","article-title":"Diffusion-weighted MRI of hepatocellular carcinoma in cirrhosis","volume":"69","author":"Lim","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jvir.2006.10.005","article-title":"Functional MR Imaging Assessment of Tumor Response after 90Y Microsphere Treatment in Patients with Unresectable Hepatocellular Carcinoma","volume":"18","author":"Kamel","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0110","article-title":"Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional Treatment","volume":"27: 20 \u201330","author":"Yuan","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000511384","article-title":"Diffusion-Weighted Imaging Reflects Tumor Grading and Microvascular Invasion in Hepatocellular Carcinoma","volume":"10","author":"Surov","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejrad.2025.112156_b0120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00261-014-0168-z","article-title":"Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images","volume":"39","author":"Chang","year":"2014","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0125","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jmri.21931","article-title":"High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma","volume":"30","author":"Muhi","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0130","doi-asserted-by":"crossref","unstructured":"Miller FH, Lopes Vendrami C, Gabr A, Horowitz JM, Kelahan LC, Riaz A, et al. Evolution of Radioembolization in Treatment of Hepatocellular Carcinoma: A Pictorial Review. Radiogr a Rev Publ Radiol Soc North Am Inc 2021;41:1802\u201318. https:\/\/doi.org\/10.1148\/rg.2021210014.","DOI":"10.1148\/rg.2021210014"},{"key":"10.1016\/j.ejrad.2025.112156_b0135","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jvir.2008.05.002","article-title":"Tumor Response after Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Comparison of Diffusion-weighted Functional MR Imaging with Anatomic MR Imaging","volume":"19","author":"Rhee","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0140","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2214\/AJR.06.0706","article-title":"Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres","volume":"188","author":"Keppke","year":"2007","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ejrad.2025.112156_b0145","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00261-014-0295-6","article-title":"Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?","volume":"40","author":"Vouche","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0150","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/01.RVI.0000227234.81718.EB","article-title":"Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization","volume":"17","author":"Deng","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00261-014-0127-8","article-title":"Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis","volume":"39","author":"Kokabi","year":"2014","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0160","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/jmri.21770","article-title":"Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results","volume":"29","author":"Schraml","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0165","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/jmri.25521","article-title":"One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma","volume":"45","author":"Barat","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0170","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1159\/000520716","article-title":"Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization","volume":"40","author":"Drewes","year":"2022","journal-title":"Dig Dis"},{"key":"10.1016\/j.ejrad.2025.112156_b0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1148\/radiol.2502072222","article-title":"Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging","volume":"250","author":"Kamel","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112156_b0180","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2214\/AJR.08.1461","article-title":"Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver","volume":"193","author":"Mannelli","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejrad.2025.112156_b0185","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jmri.21316","article-title":"Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?","volume":"27","author":"Goshima","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109351","article-title":"Response assessment of hepatocellular carcinoma treated with yttrium-90 radioembolization: inter-reader variability, comparison with 3D quantitative approach, and role in the prediction of clinical outcomes","volume":"133","author":"King","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0195","unstructured":"Do RK. LI-RADS Treatment Response. In: Chernyak V, Sirlin CB, editors. LI-RADS v2018 CT\/MRI Man., American College of Radiology; 2018."},{"key":"10.1016\/j.ejrad.2025.112156_b0200","doi-asserted-by":"crossref","DOI":"10.1186\/s40644-019-0216-6","article-title":"Prediction of hepatocellular carcinoma response to 90Yttrium radioembolization using volumetric ADC histogram quantification: Preliminary results","volume":"19","author":"Gordic","year":"2019","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13244-023-01440-7","article-title":"Magnetic resonance imaging for treatment response evaluation and prognostication of hepatocellular carcinoma after thermal ablation","volume":"14","author":"Zhang","year":"2023","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0210","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.2147\/OTT.S113909","article-title":"Intravoxel incoherent motion model-based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma","volume":"9","author":"M\u00fcrtz","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ejrad.2025.112156_b0215","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.transproceed.2019.01.161","article-title":"Intravoxel Incoherent Motion Parameters for Assessing the Efficiency of Locoregional Bridging Treatments before Liver Transplantation","volume":"51","author":"Server","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejrad.2025.112156_b0220","article-title":"Assessment of hepatocellular carcinoma response to 90Y radioembolization using dynamic contrast material\u2013 enhanced MRI and intravoxel incoherent motion diffusion-weighted imaging. Radiol Imaging","volume":"2","author":"Hectors","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2025.112156_b0225","doi-asserted-by":"crossref","first-page":"W301","DOI":"10.2214\/AJR.08.2289","article-title":"Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results","volume":"193","author":"Schraml","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejrad.2025.112156_b0230","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1258\/ar.2012.120099","article-title":"Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis","volume":"53","author":"Kim","year":"2012","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0235","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jmri.24827","article-title":"Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI","volume":"42","author":"Schelhorn","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ejrad.2025.112156_b0240","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2214\/AJR.11.7541","article-title":"The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis","volume":"199","author":"Chandarana","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejrad.2025.112156_b0245","doi-asserted-by":"crossref","first-page":"502","DOI":"10.12659\/PJR.895868","article-title":"Evaluation of Free Breathing Versus Breath Hold Diffusion Weighted Imaging in Terms Apparent Diffusion Coefficient (ADC) and Signal-to-Noise Ratio (SNR) Values for Solid Abdominal Organs","volume":"81","author":"Herek","year":"2016","journal-title":"Polish J Radiol"},{"key":"10.1016\/j.ejrad.2025.112156_b0250","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3892\/ol.2014.2228","article-title":"Utility of diffusion-weighted imaging to assess hepatocellular carcinoma viability following transarterial chemoembolization","volume":"8","author":"Yuan","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejrad.2025.112156_b0255","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejrad.2013.11.016","article-title":"Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma","volume":"83","author":"Bonekamp","year":"2014","journal-title":"Eur J Radiol"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:51:09Z","timestamp":1760219469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"alternative-id":["S0720048X25002426"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112156","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DWI\/ADC in response assessment after local-regional treatment of HCC \u2013 Pearls and Pitfalls","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112156"}}